My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 127

    1.

    Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line.

    Stiefelhagen M, Sellner L, Kleinschmidt JA, Jauch A, Laufs S, Wenz F, Zeller WJ, Fruehauf S, Veldwijk MR.

    Genet Vaccines Ther. 2008 Sep 12;6:12.PMID: 18789140 [PubMed - in process]Related articlesFree article

    2.

    Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells.

    Sellner L, Stiefelhagen M, Kleinschmidt JA, Laufs S, Wenz F, Fruehauf S, Zeller WJ, Veldwijk MR.

    Exp Hematol. 2008 Aug;36(8):957-64. Epub 2008 May 20.PMID: 18495326 [PubMed - indexed for MEDLINE]Related articles

    3.

    Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy.

    Michelfelder S, Lee MK, deLima-Hahn E, Wilmes T, Kaul F, Müller O, Kleinschmidt JA, Trepel M.

    Exp Hematol. 2007 Dec;35(12):1766-76. Epub 2007 Oct 17.PMID: 17920758 [PubMed - indexed for MEDLINE]Related articles

    4.

    Pseudotyped recombinant adeno-associated viral vectors mediate efficient gene transfer into primary human CD34(+) peripheral blood progenitor cells.

    Veldwijk MR, Sellner L, Stiefelhagen M, Kleinschmidt JA, Laufs S, Topaly J, Fruehauf S, Zeller WJ, Wenz F.

    Cytotherapy. 2010;12(1):107-12.PMID: 19929455 [PubMed - in process]Related articles

    5.

    Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells.

    White AF, Mazur M, Sorscher EJ, Zinn KR, Ponnazhagan S.

    Hum Gene Ther. 2008 Dec;19(12):1407-14.PMID: 18778196 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.

    Li Q, Miller R, Han PY, Pang J, Dinculescu A, Chiodo V, Hauswirth WW.

    Mol Vis. 2008 Sep 24;14:1760-9.PMID: 18836574 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Directed evolution of adeno-associated virus for glioma cell transduction.

    Maguire CA, Gianni D, Meijer DH, Shaket LA, Wakimoto H, Rabkin SD, Gao G, Sena-Esteves M.

    J Neurooncol. 2010 Feb;96(3):337-47. Epub 2009 Jul 19.PMID: 19618115 [PubMed - in process]Related articles

    8.

    Superior gene transfer into solid tumour cells than into human mobilised peripheral blood progenitor cells using helpervirus-free adeno-associated viral vector stocks.

    Veldwijk MR, Schiedlmeier B, Kleinschmidt JA, Zeller WJ, Fruehauf S.

    Eur J Cancer. 1999 Jul;35(7):1136-42.PMID: 10533460 [PubMed - indexed for MEDLINE]Related articles

    10.

    Capsid modifications overcome low heterogeneous expression of heparan sulfate proteoglycan that limits AAV2-mediated gene transfer and therapeutic efficacy in human ovarian carcinoma.

    Shi W, Hemminki A, Bartlett JS.

    Gynecol Oncol. 2006 Dec;103(3):1054-62. Epub 2006 Jul 25.PMID: 16870238 [PubMed - indexed for MEDLINE]Related articles

    11.

    Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo.

    Li C, Hirsch M, Asokan A, Zeithaml B, Ma H, Kafri T, Samulski RJ.

    J Virol. 2007 Jul;81(14):7540-7. Epub 2007 May 2.PMID: 17475652 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression.

    Wang H, Shayakhmetov DM, Leege T, Harkey M, Li Q, Papayannopoulou T, Stamatoyannopolous G, Lieber A.

    J Virol. 2005 Sep;79(17):10999-1013.PMID: 16103151 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components.

    Nakamura S, Nakamura R, Shibata K, Kobayashi M, Sahara N, Shigeno K, Shinjo K, Naito K, Ohnishi K, Kasahara N, Iwaki Y.

    Eur J Haematol. 2004 Oct;73(4):285-94.PMID: 15347316 [PubMed - indexed for MEDLINE]Related articles

    14.

    The role of the adeno-associated virus capsid in gene transfer.

    Van Vliet KM, Blouin V, Brument N, Agbandje-McKenna M, Snyder RO.

    Methods Mol Biol. 2008;437:51-91. Review.PMID: 18369962 [PubMed - indexed for MEDLINE]Related articles

    15.

    Directed evolution of AAV mutants for enhanced gene delivery.

    Schaffer DV, Maheshri N.

    Conf Proc IEEE Eng Med Biol Soc. 2004;5:3520-3.PMID: 17271049 [PubMed]Related articles

    16.

    Isolation of targeted AAV2 vectors from novel virus display libraries.

    Waterkamp DA, Müller OJ, Ying Y, Trepel M, Kleinschmidt JA.

    J Gene Med. 2006 Nov;8(11):1307-19.PMID: 16955542 [PubMed - indexed for MEDLINE]Related articles

    17.

    Gene transfer to primary acute myeloid leukaemia blasts and myeloid leukaemia cell lines.

    Roddie PH, Paterson T, Turner ML.

    Cytokines Cell Mol Ther. 2000 Sep;6(3):127-34.PMID: 11140881 [PubMed - indexed for MEDLINE]Related articles

    18.

    In vitro selection of viral vectors with modified tropism: the adeno-associated virus display.

    Perabo L, Büning H, Kofler DM, Ried MU, Girod A, Wendtner CM, Enssle J, Hallek M.

    Mol Ther. 2003 Jul;8(1):151-7.PMID: 12842438 [PubMed - indexed for MEDLINE]Related articles

    19.

    Complement is an essential component of the immune response to adeno-associated virus vectors.

    Zaiss AK, Cotter MJ, White LR, Clark SA, Wong NC, Holers VM, Bartlett JS, Muruve DA.

    J Virol. 2008 Mar;82(6):2727-40. Epub 2008 Jan 16.PMID: 18199646 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Proteasome inhibitors decrease AAV2 capsid derived peptide epitope presentation on MHC class I following transduction.

    Finn JD, Hui D, Downey HD, Dunn D, Pien GC, Mingozzi F, Zhou S, High KA.

    Mol Ther. 2010 Jan;18(1):135-42. Epub 2009 Nov 10.PMID: 19904235 [PubMed - in process]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk